The potential pharmacological mechanism of prunetin against osteoporosis: transcriptome analysis, molecular docking, and experimental approaches

References

• An Y, Zhang H, Wang C, Jiao F, Xu H, Wang X, Luan W, Ma F, Ni L, Tang X, et al. 2019. Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. Faseb J. 33(11):12515–12527. doi: 10.1096/fj.201802805RR.
   PubMed Web of Science ®Google Scholar
• Bhargavan B, Gautam AK, Singh D, Kumar A, Chaurasia S, Tyagi AM, Yadav DK, Mishra JS, Singh AB, Sanyal S, et al. 2009. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J Cell Biochem. 108(2):388–399. doi: 10.1002/jcb.22264.
   PubMed Web of Science ®Google Scholar
• Compston JE, McClung MR, Leslie WD. 2019. Osteoporosis. Lancet. 393(10169):364–376. doi: 10.1016/S0140-6736(18)32112-3.
   PubMed Web of Science ®Google Scholar
• Dong C, Fang Y, Shi J, Wang X, Liu Y, Zhao J, Gao X. 2021. Experimental study on prevention and treatment of postmenopausal osteoporosis by antioxidant stress of Mongolian medicine blue thorn regulating FoxO/Wnt/β-catenin pathway. Panminerva Med. doi: 10.23736/S0031-0808.21.04476-1.
   Web of Science ®Google Scholar
• Einhorn TA, Bogdan Y, Tornetta P. 3rd. 2014. Bisphosphonate-associated fractures of the femur: pathophysiology and treatment. J Orthop Trauma. 28(7):433–438. doi: 10.1097/BOT.0000000000000023.
   PubMed Web of Science ®Google Scholar
• Eisenhardt S, Fleckenstein J. 2016. Traditional Chinese medicine valuably augments therapeutic options in the treatment of climacteric syndrome. Arch Gynecol Obstet. 294(1):193–200. doi: 10.1007/s00404-016-4078-x.
   PubMed Web of Science ®Google Scholar
• Farias-Cisneros E, Hidalgo-Bravo A, Miranda-Duarte A, Casas-Ávila L, Rozental TD, Velázquez-Cruz R, Valdés-Flores M. 2020. COL1A1, CCDC170, and ESR1 single nucleotide polymorphisms associated with distal radius fracture in postmenopausal Mexican women. Climacteric. 23(1):65–74. doi: 10.1080/13697137.2019.1627313.
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. 2013. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 58(5):1836–1846. doi: 10.1002/hep.26338.
   PubMed Web of Science ®Google Scholar
• Gautam AK, Bhargavan B, Tyagi AM, Srivastava K, Yadav DK, Kumar M, Singh A, Mishra JS, Singh AB, Sanyal S, et al. 2011. Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. J Nutr Biochem. 22(4):318–327. doi: 10.1016/j.jnutbio.2010.02.010.
   PubMed Web of Science ®Google Scholar
• Gupta A, Upadhyaya S, Cha T, Schwab J, Bono C, Hershman S. 2019. Serum albumin levels predict which patients are at increased risk for complications following surgical management of acute osteoporotic vertebral compression fractures. Spine J. 19(11):1796–1802. doi: 10.1016/j.spinee.2019.06.023.
   PubMed Web of Science ®Google Scholar
• Jing Z, Wang C, Yang Q, Wei X, Jin Y, Meng Q, Liu Q, Liu Z, Ma X, Liu K, et al. 2019. Luteolin attenuates glucocorticoid-induced osteoporosis by regulating ERK/Lrp-5/GSK-3β signaling pathway in vivo and in vitro. J Cell Physiol. 234(4):4472–4490. doi: 10.1002/jcp.27252.
   PubMed Web of Science ®Google Scholar
• Khan K, Pal S, Yadav M, Maurya R, Trivedi AK, Sanyal S, Chattopadhyay N. 2015. Prunetin signals via G-protein-coupled receptor, GPR30(GPER1): Stimulation of adenylyl cyclase and cAMP-mediated activation of MAPK signaling induces Runx2 expression in osteoblasts to promote bone regeneration. J Nutr Biochem. 26(12):1491–1501. doi: 10.1016/j.jnutbio.2015.07.021.
   PubMed Web of Science ®Google Scholar
• Khan K, Sharan K, Swarnkar G, Chakravarti B, Mittal M, Barbhuyan TK, China SP, Khan MP, Nagar GK, Yadav D, et al. 2013. Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation. Osteoporos Int. 24(4):1455–1470. doi: 10.1007/s00198-012-2121-8.
   PubMed Web of Science ®Google Scholar
• Kim B, Jo C, Choi HY, Lee K. 2018. Prunetin relaxed isolated rat aortic rings by blocking calcium channels. Molecules. 23(9):2372. doi: 10.3390/molecules23092372.
   PubMed Web of Science ®Google Scholar
• Kuete V, Nono EC, Mkounga P, Marat K, Hultin PG, Nkengfack AE. 2011. Antimicrobial activities of the CH2Cl2-CH3OH (1:1) extracts and compounds from the roots and fruits of Pycnanthus angolensis (Myristicaceae). Nat Prod Res. 25(4):432–443. doi: 10.1080/14786419.2010.522577.
   PubMed Web of Science ®Google Scholar
• Lane JM, Russell L, Khan SN. 2000. Osteoporosis. Clin Orthop Relat Res. 372(372):139–150. doi: 10.1097/00003086-200003000-00016.
   Google Scholar
• Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell. 141(7):1117–1134. doi: 10.1016/j.cell.2010.06.011.
   PubMed Web of Science ®Google Scholar
• Li M, Yu Y, Xue K, Li J, Son G, Wang J, Qian W, Wang S, Zheng J, Yang C, et al. 2023. Genistein mitigates senescence of bone marrow mesenchymal stem cells via ERRα-mediated mitochondrial biogenesis and mitophagy in ovariectomized rats. Redox Biol. 61:102649. doi: 10.1016/j.redox.2023.102649.
   PubMed Web of Science ®Google Scholar
• Lin X, Xiong D, Peng YQ, Sheng ZF, Wu XY, Wu XP, Wu F, Yuan LQ, Liao EY. 2015. Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives. Clin Interv Aging. 10:1017–1033. doi: 10.2147/CIA.S54613.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu J, Tong X, Peng W, Wei S, Sun T, Wang Y, Zhang B, Li W. 2021. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of huai hua san against ulcerative colitis. Drug Des Devel Ther. 15:3255–3276. doi: 10.2147/DDDT.S319786.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Jiang ZM, Chen Y, Xiao PT, Wang ZY, Huang TQ, Liu EH. 2020. Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis. J Ethnopharmacol. 257:112871. doi: 10.1016/j.jep.2020.112871.
   PubMed Web of Science ®Google Scholar
• Lu LY, Loi F, Nathan K, Lin TH, Pajarinen J, Gibon E, Nabeshima A, Cordova L, Jämsen E, Yao Z, et al. 2017. Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. J Orthop Res. 35(11):2378–2385. doi: 10.1002/jor.23553.
   PubMed Web of Science ®Google Scholar
• Mondockova V, Adamkovicova M, Lukacova M, Grosskopf B, Babosova R, Galbavy D, Martiniakova M, Omelka R. 2018. The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women. BMC Med Genet. 19(1):174. doi: 10.1186/s12881-018-0684-8.
   PubMedGoogle Scholar
• Muñoz M, Robinson K, Shibli-Rahhal A. 2020. Bone health and osteoporosis prevention and treatment. Clin Obstet Gynecol. 63(4):770–787. doi: 10.1097/GRF.0000000000000572.
   PubMed Web of Science ®Google Scholar
• Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, Schmidt H. 2022. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 43(2):136–150. doi: 10.1016/j.tips.2021.11.004.
   PubMed Web of Science ®Google Scholar
• Nogués X, Martinez-Laguna D. 2018. Update on osteoporosis treatment. Med Clin (Barc). 150(12):479–486. doi: 10.1016/j.medcli.2017.10.019.
   PubMed Web of Science ®Google Scholar
• Ornitz DM. 2005. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 16(2):205–213. doi: 10.1016/j.cytogfr.2005.02.003.
   PubMed Web of Science ®Google Scholar
• Ou L, Kang W, Liang Z, Gao F, Dong T, Wei P, Li M. 2021. Investigation of anti-osteoporosis mechanisms of rehmanniae radix preparata based on network pharmacology and experimental verification. J Orthop Surg Res. 16(1):599. doi: 10.1186/s13018-021-02751-5.
   PubMed Web of Science ®Google Scholar
• Patel K, Patel DK. 2022. The potential therapeutic properties of prunetin against human health complications: a review of medicinal importance and pharmacological activities. Drug Metab Bioanal Lett. 15(3):166–177. doi: 10.2174/2949681015666220912104743.
   PubMedGoogle Scholar
• Rizzoli R, Reginster JY, Boonen S, Bréart G, Diez-Perez A, Felsenberg D, Kaufman JM, Kanis JA, Cooper C. 2011. Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int. 89(2):91–104. doi: 10.1007/s00223-011-9499-8.
   PubMed Web of Science ®Google Scholar
• Roscioli T, Flanagan S, Kumar P, Masel J, Gattas M, Hyland VJ, Glass IA. 2000. Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature. Am J Med Genet. 93(1):22–28. doi: 10.1002/1096-8628(20000703)93:1<22::AID-AJMG5>3.0.CO;2-U.
   PubMed Web of Science ®Google Scholar
• Shang DP, Lian HY, Fu DP, Wu J, Hou SS, Lu JM. 2016. Relationship between estrogen receptor 1 gene polymorphisms and postmenopausal osteoporosis of the spine in Chinese women. Genet Mol Res. 15(2). doi: 10.4238/gmr.15028106.
   Web of Science ®Google Scholar
• Silverstein WK, Zipursky JS, Shadowitz S. 2021. Closing the osteoporosis care gap: a teachable moment. JAMA Intern Med. 181(12):1635–1636. doi: 10.1001/jamainternmed.2021.5972.
   PubMed Web of Science ®Google Scholar
• Srivastava M, Deal C. 2002. Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med. 18(3):529–555. doi: 10.1016/s0749-0690(02)00022-8.
   PubMed Web of Science ®Google Scholar
• Su N, Jin M, Chen L. 2014. Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models. Bone Res. 2(1):14003. doi: 10.1038/boneres.2014.3.
   PubMedGoogle Scholar
• Sun J, Pan Y, Li X, Wang L, Liu M, Tu P, Wu C, Xiao J, Han Q, Da W, et al. 2022. Quercetin attenuates osteoporosis in orchiectomy mice by regulating glucose and lipid metabolism via the GPRC6A/AMPK/mTOR Signaling Pathway. Front Endocrinol. 13:849544. doi: 10.3389/fendo.2022.849544.
   PubMed Web of Science ®Google Scholar
• Tabatabaei-Malazy O, Salari P, Khashayar P, Larijani B. 2017. New horizons in treatment of osteoporosis. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 25(1):2. doi: 10.1186/s40199-017-0167-z.
   Google Scholar
• Tang Y, Yang P, Jin M, Huang S, Chen H, Chen L, Yang J, Su N. 2023. Fgfr1 deficiency in osteocytes leads to increased bone mass by enhancing Wnt/β-catenin signaling. Bone. 174:116817. doi: 10.1016/j.bone.2023.116817.
   PubMed Web of Science ®Google Scholar
• Vetrivel P, Kim SM, Ha SE, Kim HH, Bhosale PB, Senthil K, Kim GS. 2020. Compound prunetin induces cell death in gastric cancer cell with potent anti-proliferative properties: in vitro assay, molecular docking, dynamics, and ADMET studies. Biomolecules. 10(7):1086. doi: 10.3390/biom10071086.
   PubMed Web of Science ®Google Scholar
• Wu K, Han L, Zhao Y, Xiao Q, Zhang Z, Lin X. 2022. Deciphering the molecular mechanism underlying the effects of epimedium on osteoporosis through system bioinformatic approach. Medicine. 101(32):e29844. doi: 10.1097/MD.0000000000029844.
   PubMed Web of Science ®Google Scholar
• Xiang D, He J, Jiang T. 2018. The correlation between estrogen receptor gene polymorphism and osteoporosis in Han Chinese women. Eur Rev Med Pharmacol Sci. 22(23):8084–8090.
   PubMed Web of Science ®Google Scholar
• Xiao L, Zhong M, Huang Y, Zhu J, Tang W, Li D, Shi J, Lu A, Yang H, Geng D, et al. 2020. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways. Aging. 12(21):21706–21729. doi: 10.18632/aging.103976.
   PubMedGoogle Scholar
• Xie B, Wu J, Li Y, Wu X, Zeng Z, Zhou C, Xu D, Wu L. 2019. Geniposide alleviates glucocorticoid-induced inhibition of osteogenic differentiation in MC3T3-E1 cells by ERK pathway. Front Pharmacol. 10:411. doi: 10.3389/fphar.2019.00411.
   PubMed Web of Science ®Google Scholar
• Xie B, Zeng Z, Liao S, Zhou C, Wu L, Xu D. 2021. Kaempferol ameliorates the inhibitory activity of dexamethasone in the osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK pathways. Front Pharmacol. 12:739326. doi: 10.3389/fphar.2021.739326.
   PubMed Web of Science ®Google Scholar
• Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, et al. 2020. FGF/FGFR signaling in health and disease. Signal Transduct Target Ther. 5(1):181. doi: 10.1038/s41392-020-00222-7.
   PubMed Web of Science ®Google Scholar
• Yang G, Ham I, Choi HY. 2013. Anti-inflammatory effect of prunetin via the suppression of NF-κB pathway. Food Chem Toxicol. 58:124–132. doi: 10.1016/j.fct.2013.03.039.
   PubMed Web of Science ®Google Scholar
• Yu F, Xia W. 2019. The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos. 14(1):32. doi: 10.1007/s11657-018-0549-y.
   PubMed Web of Science ®Google Scholar
• Zhang S, Shen S, Ma P, Fan D. 2022. Biochemical targets and molecular mechanism of ginsenoside compound k in treating osteoporosis based on network pharmacology. Int J Mol Sci. 23(22):13921. doi: 10.3390/ijms232213921.
   PubMed Web of Science ®Google Scholar
• Zhu H, Wang M, Zhao C, Li R, Yang J, Pei G, Ye T, Zuo X, Liu L, Chong Lee Shin OL, et al. 2018. GAG and collagen II attenuate glucocorticoid-induced osteoporosis by regulating NF-κB and MAPK signaling. Am J Trans Res. 10(6):1762–1772.
   PubMed Web of Science ®Google Scholar